135 related articles for article (PubMed ID: 20222723)
1. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.
Hammond DE; Hyde R; Kratchmarova I; Beynon RJ; Blagoev B; Clague MJ
J Proteome Res; 2010 May; 9(5):2734-42. PubMed ID: 20222723
[TBL] [Abstract][Full Text] [Related]
2. Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.
Johnson H; Lescarbeau RS; Gutierrez JA; White FM
J Proteome Res; 2013 Apr; 12(4):1856-67. PubMed ID: 23438512
[TBL] [Abstract][Full Text] [Related]
3. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
4. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.
Blagoev B; Ong SE; Kratchmarova I; Mann M
Nat Biotechnol; 2004 Sep; 22(9):1139-45. PubMed ID: 15314609
[TBL] [Abstract][Full Text] [Related]
5. Phosphotyrosine Profiling Using SILAC.
Datta KK; Chatterjee A; Gowda H
Methods Mol Biol; 2023; 2603():117-125. PubMed ID: 36370274
[TBL] [Abstract][Full Text] [Related]
6. Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC).
Zhang G; Spellman DS; Skolnik EY; Neubert TA
J Proteome Res; 2006 Mar; 5(3):581-8. PubMed ID: 16512673
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling.
Zhang G; Neubert TA
J Proteome Res; 2011 Dec; 10(12):5454-62. PubMed ID: 22013880
[TBL] [Abstract][Full Text] [Related]
8. An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells.
Heibeck TH; Ding SJ; Opresko LK; Zhao R; Schepmoes AA; Yang F; Tolmachev AV; Monroe ME; Camp DG; Smith RD; Wiley HS; Qian WJ
J Proteome Res; 2009 Aug; 8(8):3852-61. PubMed ID: 19534553
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell Lines.
Broncel M; Huang PH
Methods Mol Biol; 2017; 1636():253-262. PubMed ID: 28730484
[TBL] [Abstract][Full Text] [Related]
10. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters.
Abe Y; Nagano M; Tada A; Adachi J; Tomonaga T
J Proteome Res; 2017 Feb; 16(2):1077-1086. PubMed ID: 28152594
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks.
Zhang Y; Wolf-Yadlin A; White FM
Methods Mol Biol; 2007; 359():203-12. PubMed ID: 17484120
[TBL] [Abstract][Full Text] [Related]
12. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells.
Chen Y; Low TY; Choong LY; Ray RS; Tan YL; Toy W; Lin Q; Ang BK; Wong CH; Lim S; Li B; Hew CL; Sze NS; Druker BJ; Lim YP
Proteomics; 2007 Jul; 7(14):2384-97. PubMed ID: 17570516
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.
Stebbing J; Zhang H; Xu Y; Grothey A; Ajuh P; Angelopoulos N; Giamas G
Mol Cell Proteomics; 2015 Sep; 14(9):2479-92. PubMed ID: 26089344
[TBL] [Abstract][Full Text] [Related]
14. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
16. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
17. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
Reznik TE; Sang Y; Ma Y; Abounader R; Rosen EM; Xia S; Laterra J
Mol Cancer Res; 2008 Jan; 6(1):139-50. PubMed ID: 18234969
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomics finds its timing.
Johnson SA; Hunter T
Nat Biotechnol; 2004 Sep; 22(9):1093-4. PubMed ID: 15340474
[No Abstract] [Full Text] [Related]
19. Enrichment of phosphotyrosine proteome of human platelets by immunoprecipitation.
Foy M; Harney DF; Wynne K; Maguire PB
Methods Mol Biol; 2007; 357():313-8. PubMed ID: 17172697
[TBL] [Abstract][Full Text] [Related]
20. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
